Ursodeoxycholic acid-conjugated chitosan for photodynamic treatment of HuCC-T1 human cholangiocarcinoma cells

被引:43
作者
Lee, Hye Myeong [1 ]
Jeong, Young-Il [1 ]
Kim, Do Hyung [1 ,2 ]
Kwak, Tae Won [1 ]
Chung, Chung-Wook [1 ]
Kim, Cy Hyun [1 ,2 ]
Kang, Dae Hwan [1 ]
机构
[1] Pusan Natl Univ, Yangsan Hosp, Natl Res & Dev Ctr Hepatobiliary Canc, Res Inst Convergence Biomed Sci & Technol, Gyeongnam 626770, South Korea
[2] Pusan Natl Univ, Sch Med, Yangsan 626770, Gyeongnam, South Korea
关键词
Ursodeoxycholic acid; Cholangiocarcinoma; Chlorin e6; Chitosan; Photodynamic therapy; CHLORIN E(6); THERAPY; NANOPARTICLES; DELIVERY; CANCER; E6; PROLIFERATION; PROTEIN; FOLATE;
D O I
10.1016/j.ijpharm.2013.06.035
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Chitosan was hydrophobically modified with ursodeoxycholic acid (UDCA) to fabricate nano-photosensitizer for photodynamic therapy (PDT) of HuCC-T1 cholangiocarcinoma cells. Synthesis of UDCA-conjugated chitosan (ChitoUDCA) was confirmed using H-1 NMR spectra. Chlorin E6 (Ce6) was used as a photosensitizer and incorporated into ChitoUDCA nanoparticles through formation of ion complexes. Morphology of Ce6-incorporated ChitoUDCA nanoparticles was observed using TEM and their shapes were spherical with sizes around 200-400 nm. The PDT potential of Ce6-incorporated ChitoUDCA nanoparticles were studied with HuCC-T1 human cholangiocarcinoma cells. The results showed that ChitoUDCA nanoparticles enhances of Ce6 uptake into tumor cells, phototoxicity, and ROS generation compared to Ce6 itself. Furthermore, Ce6-incorporated ChitoUDCA nanoparticles showed quenching in aqueous solution and sensing at tumor cells. We suggest that Ce6-incorporated ChitoUDCA nanoparticles are promising candidates for PDT of cholangiocarcinoma cells. (c) 2013 Elsevier B.V. All rights reserved.
引用
收藏
页码:74 / 81
页数:8
相关论文
共 47 条
  • [1] Akhlynina TV, 1999, INT J CANCER, V81, P734, DOI 10.1002/(SICI)1097-0215(19990531)81:5<734::AID-IJC12>3.0.CO
  • [2] 2-J
  • [3] Radiotherapy and Chemotherapy as Therapeutic Strategies in Extrahepatic Biliary Duct Carcinoma
    Brunner, Thomas B.
    Eccles, Cynthia L.
    [J]. STRAHLENTHERAPIE UND ONKOLOGIE, 2010, 186 (12) : 672 - 680
  • [4] Endoscopic palliation of cholangiocarcinoma
    Chahal, Prabhleen
    Baron, Todd H.
    [J]. CURRENT OPINION IN GASTROENTEROLOGY, 2006, 22 (05) : 551 - 560
  • [5] Cholangiocarcinoma treatment
    Halim Charbel
    Firas H. Al-Kawas
    [J]. Current Gastroenterology Reports, 2012, 14 (6) : 528 - 533
  • [6] Ursodeoxycholic acid-induced inhibition of DLC1 protein degradation leads to suppression of hepatocellular carcinoma cell growth
    Chung, Goh Eun
    Yoon, Jung-Hwan
    Lee, Jeong-Hoon
    Kim, Hwi Young
    Myung, Sun Jung
    Yu, Su Jong
    Lee, Sung-Hee
    Lee, Soo-Mi
    Kim, Yoon Jun
    Lee, Hyo-Suk
    [J]. ONCOLOGY REPORTS, 2011, 25 (06) : 1739 - 1746
  • [7] Anti-tumor activity of all-trans retinoic acid-incorporated glycol chitosan nanoparticles against HuCC-T1 human cholangiocarcinoma cells
    Chung, Kyu-Don
    Jeong, Young-Il
    Chung, Chung-Wook
    Kim, Do Hyung
    Kang, Dae Hwan
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2012, 422 (1-2) : 454 - 461
  • [8] Primary biliary cirrhosis and bile acids
    Corpechot, Christophe
    [J]. CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2012, 36 : S13 - S20
  • [9] Photodynamic therapy for cancer
    Dolmans, DEJGJ
    Fukumura, D
    Jain, RK
    [J]. NATURE REVIEWS CANCER, 2003, 3 (05) : 380 - 387
  • [10] Photodynamic therapy
    Dougherty, TJ
    Gomer, CJ
    Henderson, BW
    Jori, G
    Kessel, D
    Korbelik, M
    Moan, J
    Peng, Q
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1998, 90 (12): : 889 - 905